Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XULANE® safely and effectively. See full prescribing information for XULANE. XULANE® (norelgestromin and ethinyl estradiol transdermal system)Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
Xulane is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. Limitations of Use: Xulane may be less effective in preventing pregnancy in women who weigh 198 lbs. (90 kg) or more. Xulane is contraindicated for use in women with BMI ≥ 30 kg/m2 [see Contraindications (4), Warnings and Precautions (5.1) and Clinical Studies (14)].
- generic_name
- norelgestromin and ethinyl estradiol
- product_names
- norelgestromin and ethinyl estradiol
- ndc
- 0378-3340, 0378-3340-16, 0378-3340-53
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en